These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A study of a female with congenital sideroblastic anemia. Manabe Y, Seto S, Furusho K, Aoki Y. Am J Hematol; 1982 Feb; 12(1):63-7. PubMed ID: 7039309 [Abstract] [Full Text] [Related]
6. delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease. Aoki Y, Muranaka S, Nakabayashi K, Ueda Y. J Clin Invest; 1979 Nov; 64(5):1196-203. PubMed ID: 500806 [Abstract] [Full Text] [Related]
7. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase. Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, May BK. N Engl J Med; 1994 Mar 10; 330(10):675-9. PubMed ID: 8107717 [Abstract] [Full Text] [Related]
13. [Familial pyridoxine-responsive sideroblastic anaemia. One case (author's transl)]. Garbarz M, Bernard JF, Boivin P. Nouv Presse Med; 1980 Nov 22; 9(44):3345-7. PubMed ID: 7443486 [Abstract] [Full Text] [Related]
18. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia. Fujiwara T, Okamoto K, Niikuni R, Takahashi K, Okitsu Y, Fukuhara N, Onishi Y, Ishizawa K, Ichinohasama R, Nakamura Y, Nakajima M, Tanaka T, Harigae H. Biochem Biophys Res Commun; 2014 Nov 07; 454(1):102-8. PubMed ID: 25450364 [Abstract] [Full Text] [Related]
19. [Treatment of primary acquired sideroblastic anemia with pyridoxal-5-phosphate. Recent experience]. Hansen OP, Drivsholm A, Hardt F. Ugeskr Laeger; 1976 Nov 22; 138(48):3035-8. PubMed ID: 982656 [No Abstract] [Full Text] [Related]